Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Simulations Plus Inc
(NQ:
SLP
)
48.34
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Simulations Plus Inc
< Previous
1
2
3
4
Next >
Simulations Plus Announces the University+ Program
October 21, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Announces Cash Dividend
October 13, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call
October 11, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Receives New Grant Award From the FDA
September 23, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Releases ADMET Predictor® (X.3)
September 15, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus to Participate in BofA Securities and Oppenheimer Investor Conferences
September 08, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company
August 19, 2021
From
Simulations Plus, Inc.
Via
Business Wire
NMPA’s Center for Drug Evaluation Adds Licenses of GastroPlus®
August 04, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results
July 12, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Celebrates 25 Years in Business
July 08, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call
June 28, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF)
June 17, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference
May 27, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus to Present at 16th Annual Needham Virtual Technology & Media Conference
May 13, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Uplisted to The Nasdaq Global Select Market®
May 12, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Releases ADMET Predictor® (X.2)
April 27, 2021
From
Simulations Plus, Inc.
Via
Business Wire
U.S. FDA Renews Licenses of DILIsym Software
April 20, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
April 12, 2021
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company
April 07, 2021
From
Simulations Plus, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.